There has been widespread scepticism over China's official COVID data since it abruptly axed anti-virus controls last month that had shielded China's 1.4 billion people from the disease for three years. ...
The chief executive of Swiss pharmaceutical giant Novartis on Thursday warned the coronavirus pandemic will likely settle into an endemic phase and renewed calls for policymakers to sufficiently finance pandemic preparedness.
Worldwide, at least 65 million people have long COVID, and that is likely an underestimate, finds a review article published late last week in Nature Reviews Microbiology.
Pfizer’s vaccine is already in the FDA approval process and Moderna CEO Stéphane Bancel told CNBC from Davos on Wednesday that it will be filing for FDA approval for its vaccine soon — it even had a plan in place for top executives to be ready to submit over the holidays if needed.
Some 96.3% of people aged 80 and over in England were likely to have antibodies at the start of December 2022, up from 89.2% in early September.
For 75 to 79-year-olds, the proportion stands at 95.8%, up from 87.4%. ...
The figures are “likely a result of the vaccination booster campaign”, according to the Office for National Statistics (ONS), which has published the data.
Recent Comments